Real-life Treatment Outcomes of Ravulizumab in PNH

Clinical trial NCT06633536 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06633536
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Paroxysmal Nocturnal Haemoglobinuria

Start date: 2025-02-06
Primary completion: 2028-08-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.